Cannabis Insurance Reform: Federal Bills, State Laws & Market Access

Executive Summary

Federal legislation introduced in September 2026 aims to remove barriers preventing traditional insurance carriers from serving state-legal cannabis businesses, potentially transforming a market currently dominated by expensive excess and surplus (E&S) lines coverage. The proposed cannabis insurance reform bill addresses a critical infrastructure gap that has forced licensed operators to pay premiums 3-5 times higher than comparable non-cannabis businesses while receiving limited coverage options. Currently, fewer than a dozen specialty carriers actively underwrite cannabis risks nationwide, concentrating market power and leaving operators vulnerable to sudden coverage withdrawals. The legislation would clarify that providing insurance to state-compliant cannabis businesses does not constitute federal aiding and abetting of drug trafficking, opening the door for mainstream admitted carriers to enter the space. This reform carries implications for the estimated 15,000+ licensed cannabis businesses across 38 states with medical or adult-use programs, potentially unlocking billions in reduced operating costs and enabling access to standard commercial policies for property, liability, workers' compensation, and crop insurance.

Why Cannabis Insurance Reform Matters

The inability to secure affordable, comprehensive insurance represents one of the most significant operational barriers facing the $30+ billion legal cannabis industry. Unlike typical businesses that can obtain bundled commercial policies through standard admitted carriers at competitive rates, cannabis operators must piece together coverage from a handful of specialty insurers operating in the excess and surplus lines market—a sector designed for unusual or high-risk ventures. The stakeholder impact spans multiple constituencies. For licensed operators, insurance costs consume 2-4% of gross revenue compared to 0.5-1% for comparable industries, directly affecting profitability in an already capital-intensive sector with thin margins. Cultivators face particular vulnerability, as crop insurance—standard protection for agricultural businesses—remains effectively unavailable, leaving millions in inventory exposed to fire, pest infestation, and natural disasters without recourse. Employees in the cannabis sector number approximately 428,000 full-time equivalent positions as of 2026, according to industry workforce data. Workers' compensation insurance, while technically available, costs cannabis employers 30-50% more than comparable manufacturing or retail operations, with some carriers imposing coverage restrictions that leave employees with reduced benefits. Investors and lenders view insurance availability as a fundamental risk factor. Multi-state operators (MSOs) report that insurance costs and coverage gaps feature prominently in due diligence processes, with some institutional investors declining participation specifically due to insurance market instability. Real estate investors face similar challenges, as property owners leasing to cannabis tenants often cannot secure standard landlord policies, forcing them into specialty markets or declining otherwise creditworthy tenants. State regulators in the 38 jurisdictions with legal cannabis programs mandate insurance as a licensing condition, yet struggle with the reality that compliant coverage may be unavailable or prohibitively expensive. This creates a regulatory catch-22 where operators must maintain insurance to retain licenses but face a market with severe capacity constraints. The reform bill's potential to normalize insurance access would fundamentally alter cannabis business economics, potentially reducing industry-wide insurance costs by $400-600 million annually while expanding coverage breadth to match standard commercial policies.

Background and History: How Cannabis Became Uninsurable

The cannabis insurance crisis stems directly from the federal-state legal conflict created when Colorado and Washington voters approved adult-use legalization in 2012 while cannabis remained a Schedule I controlled substance under the Controlled Substances Act (21 U.S.C. § 812).

Pre-Legalization Era (Pre-2012)

Before state-level legalization, cannabis businesses operated entirely in the illicit market or as quasi-legal medical dispensaries in states like California (following Proposition 215 in 1996). Insurance was functionally unavailable, as carriers would not knowingly underwrite federally illegal activity. The few medical dispensaries that obtained coverage did so by obscuring their actual business operations or through brokers willing to misrepresent the risk to carriers—a practice that frequently resulted in claims denials and policy rescissions.

Early Legalization and the Insurance Vacuum (2012-2014)

When Colorado and Washington implemented adult-use sales in 2014, licensed operators expected to access standard business insurance. Instead, they encountered wholesale rejection from admitted carriers. The insurance industry's concern centered on potential federal prosecution under aiding and abetting statutes (18 U.S.C. § 2) and conspiracy laws (21 U.S.C. § 846). Insurers feared that paying claims for cannabis businesses could constitute facilitation of drug trafficking, exposing carriers to criminal liability and potentially jeopardizing their federal banking relationships. Lloyd's of London syndicates became the first major insurance market to explicitly serve cannabis businesses in 2014, offering coverage through surplus lines brokers. The Lloyd's market, operating under different regulatory structures than U.S. domestic carriers, proved more willing to underwrite cannabis risks, though at substantial premiums reflecting both actual risk and market novelty.

Cole Memorandum Period (2014-2018)

The Obama administration's Cole Memorandum, issued by Deputy Attorney General James Cole in August 2013, provided limited comfort to the insurance industry by deprioritizing federal enforcement against state-compliant cannabis businesses. However, the memorandum explicitly stated it did not create legal rights or alter the fact that cannabis remained federally illegal. Most admitted carriers continued to avoid the sector, viewing the Cole Memorandum as revocable guidance rather than durable legal protection. During this period, a small group of specialty E&S carriers emerged to serve the cannabis market, including Cannasure Insurance Services (launched 2014), Global Cannabinoid Solutions (2015), and several managing general underwriters (MGUs) with Lloyd's backing. These pioneers developed cannabis-specific underwriting guidelines, often requiring extensive security measures, inventory tracking integration, and higher deductibles than standard commercial policies.

Sessions Rescission and Market Contraction (2018-2019)

Attorney General Jeff Sessions rescinded the Cole Memorandum in January 2018, creating immediate uncertainty in cannabis insurance markets. Several carriers temporarily withdrew from the space or froze new policy issuance pending legal review. The rescission demonstrated the fragility of relying on prosecutorial discretion rather than statutory reform, reinforcing insurers' reluctance to commit capital and underwriting capacity to the sector. Premium rates increased 15-25% industry-wide in 2018 as carriers priced in heightened regulatory risk. Some operators found themselves unable to renew policies, forcing them to either cease operations or operate without coverage in violation of state licensing requirements.

State-Level Insurance Reforms (2019-2021)

Recognizing the insurance crisis, several states enacted legislation attempting to facilitate coverage. California Assembly Bill 1525 (2019) required the state insurance commissioner to study cannabis insurance availability and make recommendations. New York included insurance provisions in its 2021 Marijuana Regulation and Taxation Act, directing regulators to work with carriers to develop appropriate coverage options. These state efforts produced limited results, as the fundamental federal conflict remained unchanged. State insurance regulators lack authority to compel carriers to underwrite specific risks, and federal illegality continued to deter most admitted market participation.

Federal Banking Reform Attempts (2019-2026)

The Secure and Fair Enforcement (SAFE) Banking Act, first introduced in 2019 and reintroduced in subsequent Congresses, included provisions addressing insurance alongside banking access. The bill would have prohibited federal regulators from penalizing insurers solely for serving state-legal cannabis businesses. The House of Representatives passed SAFE Banking multiple times between 2019 and 2025, but the Senate never brought the measure to a floor vote, leaving the insurance provisions unenacted.

Current Market Structure (2024-2026)

As of September 2026, the cannabis insurance market remains concentrated among approximately 8-12 active carriers, nearly all operating in the E&S space. Market leaders include Cannasure, Global Cannabinoid Solutions, Trichome Insurance Services, and several Lloyd's syndicates. Combined, these carriers provide an estimated $800 million to $1.2 billion in annual premium volume across property, general liability, product liability, and workers' compensation lines. The E&S market structure means cannabis businesses pay non-admitted carrier rates without access to state guaranty fund protections. Policies typically include cannabis-specific exclusions, such as limited coverage for product recalls, restricted coverage for edibles and concentrates, and exclusions for federal seizure or forfeiture. Deductibles run 2-5 times higher than comparable admitted market policies.

Key Players in Cannabis Insurance Reform

Legislative Sponsors and Congressional Champions

The September 2026 cannabis insurance reform bill represents the first standalone federal legislation specifically addressing insurance access for state-legal cannabis businesses. According to industry reports, the bill emerged from bipartisan negotiations recognizing that comprehensive cannabis reform remains politically challenging while targeted financial infrastructure improvements attract broader support. Congressional sponsors have emphasized the bill's narrow scope—it does not legalize cannabis or alter Controlled Substances Act scheduling, but simply clarifies that providing insurance to state-compliant businesses does not constitute federal aiding and abetting. This framing aims to attract lawmakers uncomfortable with broader legalization but concerned about small business access to essential services.

Insurance Industry Organizations

The National Association of Insurance Commissioners (NAIC), representing state insurance regulators, has documented cannabis insurance availability challenges in multiple reports since 2019. State commissioners in legalized jurisdictions have advocated for federal clarity, noting that their regulatory mandate to ensure market availability conflicts with federal law deterring carrier participation. The American Property Casualty Insurance Association (APCIA), representing major admitted carriers, has not taken a formal position on cannabis insurance reform. Individual member companies maintain varying internal policies, with most prohibiting cannabis underwriting regardless of state legality. The proposed legislation would not compel carriers to serve cannabis businesses but would remove federal legal barriers for those choosing to enter the market.

Cannabis Industry Advocates

The National Cannabis Industry Association (NCIA) has prioritized insurance reform in its federal advocacy since 2017, commissioning studies documenting the cost differential between cannabis and non-cannabis insurance. NCIA estimates that normalizing insurance access would reduce industry operating costs by 1-2% of revenue, translating to $300-600 million in annual savings across the sector. The U.S. Cannabis Council, representing larger MSOs, has emphasized insurance access as critical infrastructure for institutional investment. Multi-state operators report that insurance costs and coverage gaps feature prominently in earnings calls and investor presentations, with several public companies disclosing insurance availability as a material risk factor in SEC filings.

Specialty Cannabis Insurers

The small group of carriers currently serving the cannabis market face a complex calculus regarding reform. Expanded competition from admitted carriers would likely compress premium rates and reduce the specialty market's pricing power. However, market expansion would also increase overall insurable exposure, potentially growing the total premium pool. Several specialty carriers have indicated support for reform, betting that their cannabis-specific expertise and established distribution networks would allow them to compete effectively even as larger carriers enter the space.

State Governments and Regulators

State cannabis regulators in California, Colorado, Washington, Illinois, Michigan, Massachusetts, and other mature markets have documented insurance availability as a persistent licensing and compliance challenge. Some states have established working groups with insurance commissioners to explore solutions, but consistently conclude that federal reform is necessary for meaningful improvement. State insurance departments face pressure from both licensed cannabis businesses seeking relief and admitted carriers seeking clarity on federal legal risk. The proposed federal legislation would resolve this tension by providing explicit safe harbor for insurers serving state-compliant operators.

Legal and Regulatory Framework

The cannabis insurance crisis exists at the intersection of federal drug law, insurance regulation, and state-federal conflict over cannabis policy.

Federal Controlled Substances Act

Cannabis remains a Schedule I controlled substance under the Controlled Substances Act (21 U.S.C. § 812), defined as having no accepted medical use and high potential for abuse. Federal law prohibits manufacturing, distributing, or possessing cannabis (21 U.S.C. § 841), with criminal penalties including substantial fines and imprisonment. Critically for insurance, federal law also prohibits aiding and abetting violations (18 U.S.C. § 2) and conspiracy to violate drug laws (21 U.S.C. § 846). Insurers have interpreted these provisions as potentially applying to paying claims for cannabis businesses, since claim payments could be viewed as facilitating ongoing drug trafficking operations.

Insurance Regulatory Structure

Insurance is primarily regulated at the state level under the McCarran-Ferguson Act (15 U.S.C. §§ 1011-1015), which grants states authority over insurance business. However, federal law preempts state regulation where federal statutes specifically regulate insurance or where state law conflicts with federal policy. Admitted carriers—those licensed by state insurance departments and subject to rate and form regulation—must comply with state guaranty fund requirements, file rates and policy forms for approval, and maintain capital reserves according to state standards. Surplus lines carriers operate with more flexibility, serving risks that admitted carriers decline, but without guaranty fund protection for policyholders. No state insurance regulator can compel admitted carriers to underwrite cannabis risks while federal law classifies such underwriting as potentially criminal. This creates the regulatory impasse that federal reform aims to resolve.

Proposed Federal Safe Harbor

The September 2026 cannabis insurance reform bill would amend federal law to provide that insurers, reinsurers, and insurance producers (agents and brokers) may provide insurance services to state-legal cannabis businesses without federal penalty. Specifically, the legislation would clarify that such services do not constitute aiding and abetting under 18 U.S.C. § 2, conspiracy under 21 U.S.C. § 846, or money laundering under 18 U.S.C. § 1956. The safe harbor would apply only to businesses complying with state cannabis laws and regulations. It would not protect insurers serving illicit market operators or businesses violating state licensing requirements. Federal banking regulators would be prohibited from penalizing financial institutions for banking relationships with insurers serving state-legal cannabis businesses.

Relationship to SAFE Banking Act

The proposed insurance reform incorporates language similar to SAFE Banking Act provisions but as standalone legislation. This strategic approach acknowledges that comprehensive cannabis reform faces Senate opposition while targeted financial services improvements may attract bipartisan support. If enacted, the insurance bill would complement existing state banking reforms and private sector banking initiatives serving cannabis businesses.

State-by-State Insurance Landscape

Cannabis insurance availability and cost vary significantly across the 38 states with medical or adult-use programs, reflecting differences in market maturity, regulatory structure, and state-specific insurance requirements.

California

As the largest legal cannabis market with estimated annual sales exceeding $5 billion, California presents both the greatest insurance demand and most developed specialty market. The state requires licensed operators to maintain minimum liability coverage of $5 million per occurrence for distributors and manufacturers, $2 million for retailers. Premium rates in California have stabilized since 2022 as multiple carriers compete for business, though rates remain 2-3 times higher than comparable non-cannabis operations. The California Department of Insurance has issued guidance clarifying that providing cannabis insurance does not violate state law, but cannot override federal concerns.

Colorado

Colorado's mature market (adult-use sales began January 2014) features relatively robust insurance availability through 6-8 active carriers. The state Marijuana Enforcement Division requires proof of insurance as a licensing condition but does not mandate specific coverage amounts, leaving determinations to local jurisdictions. Denver requires $1 million general liability coverage for dispensaries, while some mountain communities require $2-3 million to address wildfire risk. Workers' compensation remains mandatory for all employees, with cannabis businesses paying experience-modified rates typically 1.3-1.8 times base rates for comparable retail operations.

Illinois

Illinois launched adult-use sales in January 2020 with comprehensive insurance requirements built into its regulatory structure. The state requires cannabis businesses to maintain general liability coverage of at least $1 million per occurrence and $2 million aggregate, plus product liability coverage of $1 million per occurrence for manufacturers. Illinois explicitly prohibits insurers from denying coverage solely because a business is state-licensed for cannabis operations, though this state-law protection does not resolve federal legal concerns. Premium rates in Illinois run 20-30% higher than California due to less carrier competition in the Midwest.

Michigan

Michigan's rapidly expanding market (adult-use sales began December 2019) has experienced insurance capacity constraints as the number of licensed businesses grew from approximately 500 in 2020 to over 1,800 by 2026. The state requires $500,000 general liability coverage for retailers and $1 million for processors, relatively modest minimums that most operators exceed to secure landlord and investor confidence. Several carriers withdrew from Michigan in 2024-2025 following a wave of product liability claims related to contaminated vape cartridges, tightening the market and increasing premiums 25-40%.

Massachusetts

Massachusetts mandates comprehensive insurance as a condition of Cannabis Control Commission licensing, requiring general liability ($1 million per occurrence, $2 million aggregate), product liability ($1 million per occurrence for manufacturers), and workers' compensation. The state also requires product recall insurance for manufacturers and processors, a coverage type that fewer than half of specialty cannabis carriers offer. Massachusetts operators report the highest insurance costs nationally, with some cultivators and manufacturers paying 4-6% of gross revenue for required coverage.

New York

New York's adult-use market launched in late 2022 with insurance requirements embedded in the Office of Cannabis Management regulations. The state requires general liability coverage of $2 million per occurrence and $4 million aggregate, among the highest state minimums nationally. New York's Marijuana Regulation and Taxation Act directed the state insurance superintendent to facilitate cannabis insurance availability, resulting in outreach to carriers and publication of guidance, but limited practical impact given federal law constraints. Premium rates in New York exceed most other markets due to high minimum requirements and limited carrier competition in the Northeast.

Ohio

Ohio operates a medical-only program with insurance requirements varying by license type. The state requires cultivators to maintain $2 million general liability coverage, processors $3 million, and dispensaries $1 million. Ohio's Board of Pharmacy has granted temporary licensing extensions to operators unable to secure required coverage, acknowledging market availability challenges. Adult-use legalization efforts in Ohio include proposed insurance reforms at the state level, though federal changes would have greater impact.

Florida

Florida's medical cannabis program, one of the nation's largest with over 800,000 registered patients, requires licensed Medical Marijuana Treatment Centers to maintain $5 million general liability coverage. The high minimum reflects Florida's vertical integration model, where single licenses cover cultivation, processing, and retail. Only 3-4 carriers actively write Florida cannabis risks, creating a concentrated market with limited competition. Premium rates reflect both the high coverage limits and Florida's challenging general liability environment across all industries.

Market and Business Implications

Cannabis insurance reform would fundamentally alter industry economics, potentially reducing operating costs by $400-600 million annually while expanding coverage breadth and stability.

Impact on Multi-State Operators

Publicly traded MSOs including Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, and Verano collectively operate over 500 retail locations and dozens of cultivation and processing facilities across multiple states. These large operators currently negotiate master insurance programs covering their entire footprints, but face significant challenges. MSOs report annual insurance costs ranging from $15-30 million for operators with $500 million to $1 billion in revenue, representing 2-3% of sales compared to 0.5-1% for comparable multi-location retail or manufacturing businesses. Workers' compensation alone consumes $8-15 million annually for larger MSOs, with rates varying dramatically by state based on local carrier availability and claims experience. Admitted carrier participation would likely reduce MSO insurance costs by 30-50% through increased competition and access to standard commercial package policies. More significantly, coverage breadth would expand to include business interruption insurance with fewer exclusions, cyber liability coverage (currently difficult to obtain for cannabis businesses), and directors and officers (D&O) liability insurance with fuller coverage for securities claims.

Impact on Small and Independent Operators

Single-location dispensaries, small cultivation operations, and independent processors face disproportionate insurance challenges compared to MSOs. These operators lack negotiating leverage and often cannot meet minimum premium thresholds that make them attractive to specialty carriers. Small operators report insurance costs of 4-6% of gross revenue, a burden that significantly impacts profitability in an industry with typical net margins of 10-15%. Insurance reform would benefit small operators through increased carrier competition and potential access to small business package policies similar to those available to other retail and light manufacturing businesses. The ability to obtain coverage through standard commercial insurance agents rather than specialized cannabis brokers would reduce transaction costs and improve service quality.

Impact on Ancillary Businesses

Cannabis testing laboratories, equipment manufacturers, software providers, and other ancillary businesses face insurance challenges despite not touching the plant. Many carriers extend cannabis exclusions to any business primarily serving the cannabis industry, forcing ancillary operators into specialty markets. Testing labs report particular difficulty obtaining errors and omissions (E&O) insurance, critical coverage for businesses whose test results determine product compliance and consumer safety. Federal insurance reform would clarify that ancillary businesses serving state-legal cannabis operators do not face federal legal risk, potentially opening admitted market access for this segment even if carriers remain hesitant about plant-touching operations.

Real Estate and Landlord Impact

Property owners leasing to cannabis tenants face insurance challenges that limit cannabis real estate investment. Standard commercial property policies typically exclude cannabis operations, forcing landlords to secure specialty coverage at 2-4 times standard rates or self-insure the risk. This insurance barrier has constrained cannabis real estate investment and limited available retail and cultivation space in some markets. Insurance reform would enable property owners to secure standard landlord policies covering cannabis tenants, potentially unlocking significant real estate capital for the sector. Real estate investment trusts (REITs) and institutional property investors have cited insurance availability as a factor limiting cannabis real estate exposure.

Capital Markets and Investment Impact

Insurance availability affects cannabis business valuations and investment decisions across the capital stack. Lenders require proof of adequate insurance as a loan condition, with insurance lapses typically constituting default triggers. The inability to secure stable, comprehensive coverage increases perceived investment risk and reduces business valuations. Private equity and venture capital investors in cannabis consistently cite insurance as a due diligence concern. Several institutional investors have declined cannabis opportunities specifically due to insurance market instability and the risk of sudden coverage withdrawals. Insurance reform would address a key institutional investor concern, potentially increasing capital availability for cannabis businesses.

What Industry Experts and Stakeholders Say

Insurance industry professionals, cannabis operators, and policy analysts have offered varied perspectives on the September 2026 reform proposal and its likely impact. According to insurance brokers specializing in cannabis, the current market structure creates significant challenges for operators seeking comprehensive coverage. Brokers report that even well-capitalized, compliant businesses face coverage gaps, particularly for product liability related to edibles and concentrates, business interruption, and cyber liability. The concentration of underwriting capacity among fewer than a dozen carriers creates vulnerability to sudden market exits, as occurred when several carriers withdrew from Michigan following product liability claims. Cannabis business operators consistently identify insurance as a top-three operational challenge alongside banking access and federal tax treatment under Internal Revenue Code Section 280E. Operators note that insurance costs directly impact pricing competitiveness against illicit market alternatives, as legal businesses must factor insurance expenses into retail prices while unlicensed sellers face no such costs. State regulators in legalized jurisdictions have documented insurance availability challenges in multiple reports and working group findings. Regulators emphasize that mandating insurance as a licensing condition becomes problematic when compliant coverage may be unavailable or prohibitively expensive, creating potential regulatory enforcement dilemmas. Insurance industry analysts project that admitted carrier entry into cannabis would follow a gradual pattern rather than immediate wholesale participation. Analysts expect that regional carriers and specialty commercial lines insurers would likely enter first, followed by larger national carriers as claims experience develops and federal legal clarity solidifies. The E&S market would likely remain significant for higher-risk operations such as extraction and manufacturing, while retail and cultivation could transition substantially to admitted markets. Financial analysts covering cannabis MSOs have identified insurance reform as a potential catalyst for margin expansion and valuation multiple improvement. Analysts estimate that insurance normalization could improve EBITDA margins by 100-200 basis points for typical operators, a meaningful improvement in a sector where profitability remains elusive for many companies. Policy researchers studying cannabis legalization implementation have documented insurance access as a critical infrastructure gap that undermines legal market competitiveness. Research indicates that high operating costs in the legal market, including insurance expenses, contribute to continued illicit market activity by creating price differentials that consumers exploit.

What's Next: Legislative Path and Implementation Timeline

The September 2026 introduction of standalone cannabis insurance reform legislation opens a new pathway for federal cannabis policy change, though significant hurdles remain before enactment. The bill faces initial referral to the House Financial Services Committee and Senate Banking Committee, both of which have jurisdiction over insurance matters. Committee consideration would likely include hearings featuring testimony from insurance industry representatives, cannabis business operators, state regulators, and potentially federal law enforcement agencies regarding any concerns about the safe harbor provisions. House passage appears more likely than Senate approval, following the pattern established by SAFE Banking Act votes in previous Congresses. The House has demonstrated greater willingness to advance incremental cannabis reforms, while Senate leadership has historically blocked cannabis legislation from floor consideration. However, the narrow, technical nature of insurance reform—framed as a small business access issue rather than drug policy—may attract broader Senate support than comprehensive legalization measures. If enacted, implementation would likely follow a 180-day timeline allowing federal banking regulators to issue guidance and state insurance departments to communicate with carriers regarding the new federal safe harbor. Admitted carriers would need to develop cannabis underwriting guidelines, rate filings, and policy forms—a process typically requiring 6-12 months from decision to market entry. Industry observers project that 3-5 years would pass between enactment and full market normalization, as carriers gradually build cannabis books of business, develop claims experience, and refine underwriting standards. Initial admitted market entry would likely focus on lower-risk operations such as retail dispensaries and standard cultivation, with higher-risk activities like extraction and edibles manufacturing remaining in specialty markets longer. Parallel developments that could affect the timeline include potential DEA rescheduling of cannabis from Schedule I to Schedule III, which would reduce but not eliminate federal-state conflict, and potential enactment of broader cannabis reform legislation that could incorporate insurance provisions. The 2026 election cycle and resulting congressional composition will significantly influence legislative prospects. State insurance departments in legalized jurisdictions have begun preliminary planning for admitted carrier entry, including discussions about appropriate rate regulation, policy form standards, and consumer protection measures specific to cannabis insurance. These state-level preparations would accelerate market development if federal reform passes.

Further Reading and Primary Sources

• Controlled Substances Act, 21 U.S.C. § 812 et seq. — Federal statute classifying cannabis as Schedule I controlled substance
• McCarran-Ferguson Act, 15 U.S.C. §§ 1011-1015 — Federal law establishing state authority over insurance regulation
• National Association of Insurance Commissioners (NAIC) Cannabis Insurance Working Group reports and proceedings — https://content.naic.org
• California Department of Insurance cannabis insurance guidance and market studies — https://www.insurance.ca.gov
• Colorado Division of Insurance cannabis insurance bulletins — https://doi.colorado.gov
• Illinois Department of Insurance cannabis insurance requirements — https://insurance.illinois.gov
• National Cannabis Industry Association (NCIA) insurance access advocacy materials and industry surveys — https://thecannabisindustry.org
• U.S. Cannabis Council policy papers on financial services access — https://www.uscannabishouncil.com
• Congressional Research Service reports on cannabis banking and financial services — https://crsreports.congress.gov
• State cannabis regulatory agency insurance requirements: California Bureau of Cannabis Control, Colorado Marijuana Enforcement Division, Illinois Department of Financial and Professional Regulation
• Public company SEC filings (10-K and 10-Q reports) from Curaleaf Holdings, Green Thumb Industries, Trulieve Cannabis Corp., Cresco Labs, and Verano Holdings discussing insurance costs and availability as risk factors